dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Delgadillo Duarte, Joaquin |
dc.contributor.author | Kerkelä, Erja |
dc.contributor.author | Waters, Allison |
dc.contributor.author | van den Akker, Emile |
dc.contributor.author | Lechanteur, Chantal |
dc.contributor.author | BAUDOUX, Etienne |
dc.contributor.author | Vives, Joaquim |
dc.date.accessioned | 2023-11-27T11:20:26Z |
dc.date.available | 2023-11-27T11:20:26Z |
dc.date.issued | 2023-12 |
dc.identifier.citation | Delgadillo J, Kerkelä E, Waters A, van den Akker E, Lechanteur C, Baudoux E, et al. A management model in blood, tissue and cell establishments to ensure rapid and sustainable patient access to advanced therapy medicinal products in Europe. Cytotherapy. 2023 Dec;25(12):1259–64. |
dc.identifier.issn | 1465-3249 |
dc.identifier.uri | https://hdl.handle.net/11351/10661 |
dc.description | Advanced therapy medicinal product; Business model; Cell processing |
dc.description.abstract | Blood, tissue and cell establishments (BTCs) stand out in the management of donor selection, procurement and processing of all types of substances of human origin (SoHO). In the last decades, the framework created around BTCs, including hospitals and national health system networks, and their links to research, development and innovation organizations and agencies have spurred their involvement in the study of groundbreaking advanced therapy medicinal products (ATMP). To further improve strategic synergies in the development of ATMPs, it will be required to promote intra- and inter-European collaborations by creating an international network involving BTCs and major stakeholders (i.e., research organizations, hospitals, universities, patient associations, public agencies). This vision is already shared with the European Blood Alliance, the association of non-profit blood establishments, with 26 member states throughout the European Union and European Free Trade Association states. Herein we present and analyze the “BTC for ATMP Development And Manufacture” (BADAM) model, an ethically responsible business model based on the values and missions of BTCs and their commitment to health equity, patient access and education (based on voluntary donation of SoHO to address unmet clinical needs, while contributing to training professionals and scientific literacy of our Society). |
dc.language.iso | eng |
dc.publisher | Elsevier |
dc.relation.ispartofseries | Cytotherapy;25(12) |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.source | Scientia |
dc.subject | Diferenciació cel·lular |
dc.subject | Teràpia cel·lular |
dc.subject | Bancs de teixits |
dc.subject.mesh | Cell Differentiation |
dc.subject.mesh | Cell- and Tissue-Based Therapy |
dc.subject.mesh | Tissue Banks |
dc.title | A management model in blood, tissue and cell establishments to ensure rapid and sustainable patient access to advanced therapy medicinal products in Europe |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1016/j.jcyt.2023.08.001 |
dc.subject.decs | diferenciación celular |
dc.subject.decs | tratamientos basados en células y tejidos |
dc.subject.decs | bancos de tejidos |
dc.relation.publishversion | https://doi.org/10.1016/j.jcyt.2023.08.001 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Delgadillo J] Banc de Sang i Teixits (BST), Edifici Dr. Frederic Duran i Jordà, Barcelona, Spain. Grup de Recerca de Medicina Transfusional, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Kerkelä E] Irish Blood Transfusion Service, National Blood Centre, Dublin, Ireland. [Waters A] Irish Blood Transfusion Service, National Blood Centre, Dublin, Ireland. [van den Akker E] Department of Hematopoiesis and Sanquin Research, Landsteiner Laboratory, Department of Molecular Hematology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands. [Lechanteur C, Baudoux E] University of Liège, Laboratory of Cell and Gene Therapy LTCG, Liège, Belgium. [Vives J] Banc de Sang i Teixits (BST), Edifici Dr. Frederic Duran i Jordà, Barcelona, Spain. Grup de Recerca d’Enginyeria Tissular Musculoesquelètica, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain |
dc.identifier.pmid | 37737767 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |